Cargando…
MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas
The monoclonal antibody G250 (mAbG250) raised against a human renal cell carcinoma (RCC) has been shown to react with a large number of RCCs. Recently, G250 antigen was isolated and found to be homologous to the MN/CA9 gene originally identified in HeLa cells. To determine whether G250 antigen (MN/C...
Autores principales: | Uemura, H, Nakagawa, Y, Yoshida, K, Saga, S, Yoshikawa, K, Hirao, Y, Oosterwijk, E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362900/ https://www.ncbi.nlm.nih.gov/pubmed/10574265 http://dx.doi.org/10.1038/sj.bjc.6690757 |
Ejemplares similares
-
Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma
por: Cho, M, et al.
Publicado: (2001) -
Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma
por: Oosterwijk-Wakka, Jeannette C., et al.
Publicado: (2013) -
Human tumour-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion
por: Závada, J, et al.
Publicado: (2000) -
Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice
por: Takehara, Y, et al.
Publicado: (2001) -
A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients
por: Bleumer, I, et al.
Publicado: (2004)